Abstract
OS-019 Efficacy and safety of seladelpar in patients with primary biliary cholangitis and compensated liver cirrhosis in the open-label, long-term ASSURE safety study: interim results
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have